NCT03497494

Brief Summary

Obesity and related metabolic diseases have become a chronic disease that is a threat to human health. Bariatric surgery can effectively and long-term reduce excess body weight and relieve related metabolic diseases, including type 2 diabetes. Laparoscopic gastric bypass surgery and laparoscopic sleeve gastrectomy are commonly used in bariatric surgery. Laparoscopic sleeve gastrectomy due to simple operation, good weight loss, and metabolic disease control effect, which is more widely used. However, there are several studies that show an increased chance of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy. Long-term gastroesophageal reflux may lead to Barrett's esophagus or esophageal cancer. Nowadays, the cause of gastroesophageal reflux disease after sleeve gastrectomy is not clear and precautionary measures are not precise. In this study, prospective randomized controlled trials were conducted to explore the possible causes of gastroesophageal reflux after sleeve gastrectomy and to explore ways to prevent gastroesophageal reflux disease after sleeve gastrectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 15, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 13, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

April 13, 2018

Status Verified

April 1, 2018

Enrollment Period

1.9 years

First QC Date

March 15, 2018

Last Update Submit

April 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • GERD-Health Related Quality of Life Questionnaire

    Total Score: Calculated by summing the individual scores to questions 1-15. * Greatest possible score (worst symptoms) = 75 * Lowest possible score (no symptoms) = 0 Heartburn Score: Calculated by summing the individual scores to questions 1-6 . * Worst heartburn symptoms = 30 * No heartburn symptoms = 0 * Scores of ≤ 12 with each individual question not exceeding 2 indicate heartburn elimination. 2 Regurgitation Score: Calculated by summing the individual scores to questions 10-15. * Worst regurgitation symptoms = 30 * No regurgitation symptoms = 0 * Scores of ≤ 12 with each individual question not exceeding 2 indicate regurgitation elimination.

    1 year

Secondary Outcomes (8)

  • preoperative and postoperative of abdominal ultrasound to examine the abdominal fat thickness

    1 year

  • Preoperative and postoperative BMI

    1 year

  • Preoperative and postoperative waist circumference

    1 year

  • Preoperative and postoperative abdominal circumference

    1 year

  • Preoperative and postoperative chest circumference

    1 year

  • +3 more secondary outcomes

Study Arms (2)

Without hiatal suture

ACTIVE COMPARATOR

the different distance of pylorus without hiatal suture

Procedure: 2 cm away from the pylorus edgeProcedure: 4 cm away from the pylorus edgeProcedure: 6 cm away from the pylorus edgeProcedure: LRYGB

With hiatal suture

ACTIVE COMPARATOR

the different distance of pylorus without hiatal suture

Procedure: 2 cm away from the pylorus edgeProcedure: 4 cm away from the pylorus edgeProcedure: 6 cm away from the pylorus edge

Interventions

2 cm away from the pylorus edge

With hiatal sutureWithout hiatal suture

4 cm away from the pylorus edge

With hiatal sutureWithout hiatal suture

6 cm away from the pylorus edge

With hiatal sutureWithout hiatal suture
LRYGBPROCEDURE

laparoscopic Roux-en-Y gastric bypass

Also known as: laparoscopic Roux-en-Y gastric bypass
Without hiatal suture

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For the choice of surgical approach, numerous studies have shown that BMI ≧ 45, the general choice of gastric bypass surgery, BMI \<45, you can choose sleeve gastrectomy. The remission rate for T2DM, sleeve gastrectomy has a good result for young patients with shorter duration. In our country, the BMI less than 45 is majorities.

You may not qualify if:

  • BMI\<27.5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The frist affiliated hospital of Jinan University

Guangzhou, Guangdong, 510630, China

Location

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: All patients enrolled in this study underwent laparoscopic sleeve gastrectomy. According to the starting point of resection to pylorus distance and whether to the strengthen suture of esophageal hole, the cases were randomly divided into 6 groups: G1: 2 cm away from the pylorus edge, without hiatal suture; G2: 4 cm away from the pylorus edge, without hiatal suture; G3: 6 cm away from the pylorus edge, without hiatal suture; G4: 2 cm away from the pylorus edge, with hiatal suture G5: 4 cm away from the pylorus edge, with hiatal suture; G6: 6 cm away from the pylorus edge, with hiatal suture;
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of bariatric surgery

Study Record Dates

First Submitted

March 15, 2018

First Posted

April 13, 2018

Study Start

January 20, 2018

Primary Completion

December 30, 2019

Study Completion

December 30, 2020

Last Updated

April 13, 2018

Record last verified: 2018-04

Locations